Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 3.69B | 3.72B | 3.73B | 3.82B | 3.87B | 3.51B |
Gross Profit | 1.90B | 1.89B | 1.89B | 1.92B | 1.95B | 1.72B |
EBITDA | 381.01M | 392.47M | 441.06M | 365.22M | 423.05M | 272.79M |
Net Income | 194.00M | 153.41M | 184.60M | 183.55M | 239.86M | 113.25M |
Balance Sheet | ||||||
Total Assets | 2.74B | 2.79B | 2.73B | 2.58B | 2.85B | 2.90B |
Cash, Cash Equivalents and Short-Term Investments | 112.80M | 107.96M | 123.00M | 70.56M | 400.96M | 514.15M |
Total Debt | 1.51B | 1.60B | 1.68B | 1.73B | 1.94B | 2.34B |
Total Liabilities | 1.98B | 2.16B | 2.22B | 2.28B | 2.57B | 2.88B |
Stockholders Equity | 762.91M | 628.53M | 508.75M | 293.64M | 280.74M | 15.44M |
Cash Flow | ||||||
Free Cash Flow | 186.89M | 145.36M | 158.57M | 57.25M | 307.96M | 316.03M |
Operating Cash Flow | 264.63M | 246.53M | 249.31M | 156.50M | 381.86M | 426.89M |
Investing Cash Flow | -57.82M | -108.91M | -99.78M | -102.42M | -76.02M | -123.78M |
Financing Cash Flow | -193.76M | -153.73M | -100.82M | -373.68M | -419.97M | 139.76M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $23.80B | 20.68 | 50.44% | ― | 1.06% | -0.29% | |
72 Outperform | $1.34B | 7.31 | 28.94% | ― | -0.38% | 35.78% | |
72 Outperform | $16.43B | 44.32 | 76.24% | ― | 7.64% | 369.79% | |
65 Neutral | $6.58B | 8.31 | -52.83% | 2.57% | -0.93% | -4.07% | |
61 Neutral | $17.70B | 12.60 | -3.90% | 3.04% | 1.52% | -15.30% | |
56 Neutral | $933.91M | 77.05 | -0.15% | ― | -3.43% | -102.60% | |
51 Neutral | $944.32M | ― | -16.81% | ― | 0.23% | 26.92% |
On August 5, 2025, Sally Beauty Holdings reported its third-quarter fiscal 2025 results, highlighting a 1.0% decrease in consolidated net sales to $933 million and a 0.4% drop in comparable sales. Despite these declines, the company achieved a fourth consecutive quarter of operating margin expansion and double-digit earnings per share growth, driven by its ‘Fuel for Growth’ program. The company also strengthened its balance sheet by repaying $21 million in term loan debt and repurchasing shares worth $13 million. Additionally, Sally Beauty raised its full-year adjusted operating margin guidance, reflecting confidence in its strategic initiatives amid a challenging macroeconomic environment.
The most recent analyst rating on (SBH) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Sally Beauty stock, see the SBH Stock Forecast page.
On July 2, 2025, Sally Beauty Holdings, Inc. adopted new Amended and Restated By-Laws to enhance procedural mechanics and disclosure requirements for stockholder nominations and proposals. These changes aim to improve transparency and governance by defining terms, requiring disclosures, and clarifying the powers of the Board and meeting chairs, impacting the company’s operational governance and stakeholder engagement.
The most recent analyst rating on (SBH) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Sally Beauty stock, see the SBH Stock Forecast page.
On June 12, 2025, Sally Beauty Holdings appointed Max Rangel, a seasoned executive with extensive experience in the consumer products industry, to its Board of Directors. Mr. Rangel’s appointment is expected to bring valuable insights and expertise to the company as it continues to focus on strategic initiatives and profitable growth, enhancing its position in the beauty industry.
The most recent analyst rating on (SBH) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Sally Beauty stock, see the SBH Stock Forecast page.